About Redbud Medicine
Redbud Medicine is a company based in Beijing (China) founded in 2019. It operates as a B2B. Redbud Medicine has raised $10 million across 1 funding round from investors including Delian Capital and Juming Venture Capital. Redbud Medicine operates in a competitive market with competitors including OncoTheis, AlphaVax, Lukas Biomedical, DXOCRO and Oncosyne, among others.
- Headquarter Beijing, China
-
Sectors
Agriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series A
Aug 23, 2022
-
Investors
Delian Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Redbud Medicine
Unlock access to complete
Funding Insights of Redbud Medicine
Redbud Medicine has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Redbud Medicine
Redbud Medicine has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Delian Capital and Juming Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Redbud Medicine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Redbud Medicine
Investment portfolio details for Redbud Medicine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Redbud Medicine
Detailed financials for Redbud Medicine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Redbud Medicine Comparisons
Peer comparison for Redbud Medicine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Redbud Medicine
Redbud Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OncoTheis, AlphaVax, Lukas Biomedical, DXOCRO and Oncosyne, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and cancer immunotherapy are developed.
|
|
| Locked | Locked | Locked |
A biotechnology company developing autologous immune cell therapies to treat various types of cancer.
|
|
| Locked | Locked | Locked |
Provides in vitro diagnostic services for oncology research and development.
|
|
| Locked | Locked | Locked |
Offers tumoroid-based platforms for cancer drug screening and personalized medicine services.
|
Detailed competitors of Redbud Medicine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Redbud Medicine
Complete news archive for Redbud Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Redbud Medicine
Redbud Medicine was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Redbud Medicine is headquartered in Beijing, China.
Redbud Medicine is a funded company, having raised a total of $10M across 1 funding round to date.
Redbud Medicine, established in 2019, excels in providing healthcare solutions, advancing biotech innovations, regulatory services, and rd support. Offers comprehensive services in regulatory affairs, RD, data management, and statistical analysis for healthcare. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Redbud Medicine's top competitors include Ontogen, AlphaVax and Cancer Research For Oza Rks.
Redbud Medicine has 2 investors. Key investors include Delian Capital, and Juming Venture Capital.